Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04899089 · ClinicalTrials.gov registry record · NA

Cognitive Training in Mild Cognitive Impairment

A NA study of Mild Cognitive Impairment and Insomnia, sponsored by University of Missouri-Columbia.

Completed
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT04899089: Completed NA study of Mild Cognitive Impairment and Insomnia, sponsored by University of Missouri-Columbia.

NCT04899089 is a NA study of Mild Cognitive Impairment and Insomnia that has completed, run by University of Missouri-Columbia. The registered enrollment target is 48 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04899089, a NA study of Mild Cognitive Impairment and Insomnia, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

Older adults (60+ years of age) who meet criteria for mild cognitive impairment and insomnia will be randomly assigned to cognitive training or trivia training and will complete measures of anxiety, sleep, cognition (objective, self-efficacy), and arousal at baseline, and post-intervention. For cognitive training, participants will be provided with login information to access the computerized training, and will complete 8 weeks (45 mins 3x/week) of cognitive training. For trivia training, participants will receive weekly emails that contain trivia assignments that they will complete for 8 weeks (45 mins 3x/week). We will evaluate short-term (i.e., post-training) effects of the two training conditions on subjective anxiety, sleep, arousal, and subjective and objective cognition.

Primary Outcome

Complete computerized tasks. These tasks will measure cognitive functions (e.g., processing speed, attention, memory).

Interventions

  • BEHAVIORAL Cognitive Training
  • BEHAVIORAL Trivia Training

Study Locations (1)

Missouri

  • University of Missouri - Columbia

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2021-07-28
Est. Completion 2023-06-01
Phase NA
University of Missouri-Columbia

291 total trials

What the finished NCT04899089 record still lists

NCT04899089 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Training is the first listed.

NCT04899089 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT04899089 about?

NCT04899089 is a clinical study titled "Cognitive Training in Mild Cognitive Impairment". Older adults (60+ years of age) who meet criteria for mild cognitive impairment and insomnia will be randomly assigned to cognitive training or trivia training and will complete measures of anxiety, sleep, cognition (objective, self-efficacy), and arousal at baseline, and post-intervention. For cogn...

What is the current status of trial NCT04899089?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2021-07-28. Estimated completion is 2023-06-01.

What conditions does trial NCT04899089 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Insomnia.

What interventions are being tested in trial NCT04899089?

The interventions under investigation include: Cognitive Training (BEHAVIORAL), Trivia Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT04899089?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04899089 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04899089's enrollment target sits among peer trials

48 145th of 205 higher than 58 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04899089, the US trial registry maintained by the National Library of Medicine. NCT04899089 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.